Ottawa’s Pythian to bolster European operations with $15M financing round
Fast-growing Ottawa IT services firm Pythian has landed a new round of investment to help fund its ambitious expansion plans, announcing this week it closed
Skip to content
Look inside: Impact Hub Ottawa triples space with new Slater Street location
Five years after first making its impact, Ottawa’s hub for social enterprise has moved into an office with the room and functionality to provide resources
Look inside: Impact Hub Ottawa triples space with new Slater Street location
Five years after first making its impact, Ottawa’s hub for social enterprise has moved into an office with the room and functionality to provide resources
Ottawa’s ‘legendary’ Zaphod Beeblebrox closing its doors
Zaphod Beeblebrox, a staple of the ByWard Market for nearly three decades, will say goodbye later this month. In a post on its website, the
Opinion: ‘Superclusters’ a super-sized opportunity for Ottawa’s tech sector
If last month’s budget is any indication, the federal Liberals are prepared to do much more than just pay lip service to their “innovation agenda.”
Canadian workforce seeing baby boomer boon, but lacks young talent: Statistics Canada
After nearly four decades in the workforce, 64-year-old Louise Plouffe is looking ahead to retirement. But Tristan Plummer, 23, is looking for work. Plouffe and
Espial’s strong North American results drive 63 per cent revenue growth in Q1
Ottawa-based Espial Group (TSX:ESP) saw net growth from mixed regional results in its first quarter of 2017, as significant gains in the firm’s North American sales
Two-thirds of electricity in Canada now comes from renewable energy
The National Energy Board says two-thirds of Canada’s electricity supply now comes from renewable sources such as hydro, wind power and solar energy. The board
Canada to see some ‘modest’ gains from trade deal with Europe: budget watchdog
Canada’s free-trade pact with Europe is poised to produce “modest” economic gains that work out to an average annual income boost of $220 per Canadian,
Valeant shareholders vent frustrations at drugmaker’s annual meeting
Shareholders in Valeant Pharmaceuticals (TSX:VRX) used the company’s annual general meeting Tuesday as a forum to vent their gripes with the struggling drugmaker. Some stockholders
Get our email newsletters
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
The Latest
Video
OBJ360
Sponsored
Sponsored
The Ottawa Hospital Foundation’s Campaign to Create Tomorrow
The $500-million fundraising campaign is the largest in our city’s history. It will reshape the future of healthcare in Ottawa and beyond.
